RxDoctor Payments Data

Paayal Patel

Neurology · West Palm Beach, FLNPI 1659501211

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Janssen Research & Development, LLC at 28.6% of the total. Reporting peaked in 2024 at $2,466 and has fallen 97.4% since, to $64 in 2025.

$3,301in general payments, 2019–2025

Across 34 payments — averaging $97.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$945
  • E.r. Squibb & Sons, L.L.C.$773
  • Merck$703
  • Eisai Inc.$651
  • Biogen$185
  • Medtronic$43
$17,320,298in research payments, 2019–2025

Across 793 payments — averaging $21,841 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$13.4M
  • Biogen$1.3M
  • Eisai Inc.$848K
  • Janssen Research & Development, LLC$584K
  • Novo Nordisk AS$306K
  • GSK$298K
  • plus $604K from 5 others

What the payments were for

  • Travel & lodging$1,95759%
  • Food & beverage$1,34441%

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,301 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Other neurology in West Palm Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →